Before the Open (Jul 14)

Good morning. Happy Friday.
The Asian/Pacific markets closed with a lean to the upside. Japan, Hong Kong, New Zealand, Australia and Singapore closed up; the Philippines finished down. Europe, Africa and the Middle East are currently mixed and very quiet. Denmark, Russia and Sweden are up; Poland and Hungary are down. Futures in the States point towards a mixed and flat open for the cash market.
—————
VIDEO: The Most Interesting Chart Out There
—————
The dollar is down a little. Oil and copper are up. Gold and silver are up. Bonds are up.
Stock headlines from barchart.com…
Boeing (BA -0.10%) was upgraded to ‘Overweight’ rom ‘Neutral’ at JPMorgan Chase with a price target of $240.
Wal-Mart (WMT +1.50%) was upgraded to ‘Buy’ from ‘Neutral’ at Goldman Sachs with a price target of $84.
Alliance Data Systems (ADS +1.65%) was initiated with a ‘Buy’ recommendation at Argus Research with a 12-month target price of $309.
GGP Inc (GGP +1.78%) was initiated with a ‘Buy’ rating at Stifel with a 12-month target price of $27.
Orion Engineered Carbons SA (OEC +0.24%) was upgraded to ‘Buy’ from ‘Neutral’ at Goldman Sachs with a target price of $25.
Mylan NV (MYL +1.22%) gained almost 2% in after-hours trading after it announced the FDA’s Oncologic Drugs Advisory Committee recommended approval of its MYL-14010, a proposed biosimilar to Roche’s Herceptin cancer drug, for the treatment of breast cancer.
CyberArk Software Ltd (CYBR +1.11%) tumbled over 18% in after-hours trading after it reported Q2 preliminary revenue of $57 million-$57.5 million, below previous guidance of $61 million-$62 million, and weaker than consensus of $61.9 million. FireEye (FEYE +0.06%) slid over 3%, Fortinet (FTNT +1.44%) dropped nearly 3% and Palo Alto Networks (PANW +1.16%) lost nearly 2% after CyberArk reported its weaker-than-expected Q2 results.
MiMedx Group (MDXG -3.28%) rose almost 4% in after-hours trading after it reported Q2 preliminary revenue of $76.4 million, above an April 28 view of $73.5 million-$75 million and higher than consensus of $74.2 million.
Juno Therapeutics (JUNO +0.11%) lost almost 2% in after-hours trading after 7 million shares of its stock were being offered via Morgan Stanley.
Consolidated Communications Holdings (CNSL -1.92%) fell over 2% in after-hours trading after 3.7 million shares of its stock were being offered via Morgan Stanley.
A10 Networks (ATEN +0.37%) slumped over 15% in after-hours trading after it lowered guidance on Q2 revenue to $52.5 million-$53.5 million from an April 27 estimate of $62 million-$64 million, well below consensus of $62.8 million.
Sangamo Therapeutics (SGMO +2.70%) climbed almost 4% in after-hours trading after the FDA awarded fast track designation for its SB-318 and SB-913 for the treatment of Mucopolysaccharidosis Type 1 and Type 2.
BioLife Solutions (BLFS +8.68%) jumped over 10% in after-hours trading after it received approval for its Invossa cell and gene therapy for degenerative arthritis from the Korea Ministry of Food and Drug Safety.
ClearSign Combustion (CLIR -2.70%) surged 25% in after-hours trading after it received an order from a ‘Supermajor’ oil company to qualify its Duplex combustion technology as a precursor to an installation at a major oil refinery.
Today’s Economic Calendar
8:30 Consumer Price Index
8:30 Retail Sales
9:15 Industrial Production
10:00 Business Inventories
10:00 Consumer Sentiment
1:00 PM Baker-Hughes Rig Count
Other…
today’s upgrades/downgrades from briefing.com
this week’s Earnings from Morningstar
this week’s Economic Numbers/Reports powered by ECONODAY